Alliance A071401: Phase II trial of FAK inhibition in meningiomas with somatic NF2 mutations
- Citation:
- J Clin Oncol vol 38 (15 suppl) 2502
- Meeting Instance:
- ASCO 2020
- Year:
- 2020
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Preliminary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3667
- Pharmas:
- GSK, Genentech
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Priscilla K. Brastianos Erin L. Twohy Elizabeth R. Gerstner Timothy J. Kaufmann A. John Iafrate Suriya Jeyapalan David E. Piccioni Mohammed M. Milhem Andrew B. Lassman Camilo E. Fadul David Schiff Jennie W. Taylor Sajeel Akbar Chowdhary Chetan Bettegowda George Ansstas Frank S. Lieberman Nicole Shonka Thomas Kaley Tara Morrison Alissa A. Thomas Mary R. Welch Fabio Iwamoto David Cachia Adam L. Cohen Priya Kumthekar Ian Dunn Jann Sarkaria Susan Geyer Xiomara W. Carrero Maria Martinez-Lage Paul D. Brown Daniel P. Cahill Caterina Giannini Sandro Santagata Frederick G. Barker II Evanthia Galanis
- Networks:
- CA136, CA249, COLUMBIA, FL086, IA018, LAPS-IL036, LAPS-MA036, LAPS-MD017, LAPS-MN026, LAPS-MO011, LAPS-NY016, LAPS-OK003, LAPS-PA015, MA011, MCRC, NE003, RI005, VA002, VA009, VT004
- Study
- Alliance-A071401
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: